Lack Of Diversity In Clinical Trials Presents Possible Health Consequences
By Rae Ellen Bichell,
National Public Radio
| 12. 17. 2015
Untitled Document
Despite striking ethnic disparities in the incidence and mortality of diseases like cancer and respiratory disease, minorities are not well represented in clinical trials. A paper out in the journal PLOS Medicine says two main barriers to achieving diverse clinical trials are the expense of recruiting minority subjects, and fears of exploitation in medical research.
ARI SHAPIRO, HOST:
About 40 percent of Americans belong to a racial or ethnic minority. But the people who participate in clinical trials are much more homogeneous. These trials are the studies that test whether drugs work and inform doctors' decisions about how to treat their patients. As NPR's Rae Ellen Bichell reports, that mismatch can have big health consequences.
RAE ELLEN BICHELL, BYLINE: Here's the gist of an article this week in the journal PLOS Medicine - clinical trials in biomedical research are too white.
SAM OH: Yeesh (laughter) it's a little jarring to hear it that way.
BICHELL: But that's the reality. Sam Oh is an epidemiologist at UC San Francisco. He was one of a group of 14 researchers who...
Related Articles
By Susanna Smith, Genetic Frontiers | 07.28.2025
Key Topics
How does the American far right view genetics and genetic technologies?
What is the history of the American cultural pursuit of trying to choose smarter children? What has science shown us about the relationship of heredity and intelligence...
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Maren Behrensen, Tech Policy Press | 07.02.2025
Why is it dangerous when corporate executives, entrepreneurs and investors with enormous wealth and power collectively control the development and deployment of our most pervasive technologies? Most answers to this question focus on the technologies themselves, or the ways in...
By Philip Bump, Washington Post | 07.07.2025
There are a lot of questions worth asking about the New York Times’s report on Thursday about New York City Democratic mayoral nominee Zohran Mamdani. The most obvious is how Mamdani’s racial self-identification in his 2009 application to Columbia University...
